| 中文名 | 巴非替尼 |
|---|---|
| 英文名 | 4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(5-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide |
| 中文别名 |
BCR-ABL和LYN双重抑制剂(LYN-IN-1)
BCR-ABL/LYN抑制剂(BAFETINIB) N-[3-([5,5'-联嘧啶]-2-基氨基)-4-甲基苯基]-4-[[(3S)-3-(二甲基氨基)-1-吡咯烷基]甲基]-3-(三氟甲基)苯甲酰胺 巴非替尼,10 MM DMSO 溶液 |
| 英文别名 |
Lyn-IN-1 (Synonyms: Bafetinib analog)
Tetrazobenzene-β-naphthol Lyn-IN-1, 10 mM in DMSO N-[3-(5,5'-Bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl}-3-(trifluoromethyl)benzamide QCR-131 Bafetinib, >= cc-271 Bafetinib //BP (S)-N-(3-(5,5'-Bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)-pyrrolidin-1-yl)me Lyn-IN-1 Bafetinib analog S1369_Selleck (S)-N-(3-([5,5'-bipyriMidin]-2-ylaMino)-4-Methylphenyl)-4-((3-(diMethylaMino)pyrrolidin-1-yl)Methyl)-3-(trifluoroMethyl)benzaMide N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide Bafetinib Lyn-IN-1 Benzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl) N-[3-({[5,5'-bipyrimidin]-2-yl}amino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide INNO-406,NS-187,Bafetinib bafetinib |
| 描述 | Lyn-IN-1是高活性Bcr-Abl和Lyn双重抑制剂, |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 分子式 | C30H31F3N8O |
| 分子量 | 576.615 |
| 精确质量 | 576.257263 |
| PSA | 99.17000 |
| LogP | 3.03 |
| 折射率 | 1.640 |
| 储存条件 | 2-8°C,避光,保存于惰性气体中 |